246 related articles for article (PubMed ID: 22789030)
1. Comparison of 8-hydroxy-2'-deoxyguanosine (8-OHdG) levels using mass spectrometer and urine albumin creatinine ratio as a predictor of development of diabetic nephropathy.
Serdar M; Sertoglu E; Uyanik M; Tapan S; Akin K; Bilgi C; Kurt I
Free Radic Res; 2012 Oct; 46(10):1291-5. PubMed ID: 22789030
[TBL] [Abstract][Full Text] [Related]
2. Oxidative stress markers in type 2 diabetes patients with diabetic nephropathy.
Chou ST; Tseng ST
Clin Exp Nephrol; 2017 Apr; 21(2):283-292. PubMed ID: 27233502
[TBL] [Abstract][Full Text] [Related]
3. Study of urinary 8-hydroxydeoxyguanosine as a biomarker of oxidative DNA damage in diabetic nephropathy patients.
Xu GW; Yao QH; Weng QF; Su BL; Zhang X; Xiong JH
J Pharm Biomed Anal; 2004 Sep; 36(1):101-4. PubMed ID: 15351053
[TBL] [Abstract][Full Text] [Related]
4. Rapid extraction and analysis of oxidative stress and DNA damage biomarker 8-hydroxy-2'-deoxyguanosine (8-OHdG) in urine: Application to a study with pregnant women.
Bláhová L; Janoš T; Mustieles V; Rodríguez-Carrillo A; Fernández MF; Bláha L
Int J Hyg Environ Health; 2023 May; 250():114175. PubMed ID: 37105016
[TBL] [Abstract][Full Text] [Related]
5. New biomarker evidence of oxidative DNA damage in patients with non-insulin-dependent diabetes mellitus.
Leinonen J; Lehtimäki T; Toyokuni S; Okada K; Tanaka T; Hiai H; Ochi H; Laippala P; Rantalaiho V; Wirta O; Pasternack A; Alho H
FEBS Lett; 1997 Nov; 417(1):150-2. PubMed ID: 9395094
[TBL] [Abstract][Full Text] [Related]
6. Association between urinary 8-OHdG and pulse wave velocity in hypertensive patients with type 2 diabetes mellitus.
Kotani K; Yamada T
Singapore Med J; 2014 Apr; 55(4):202-8. PubMed ID: 24763836
[TBL] [Abstract][Full Text] [Related]
7. The meaning of serum levels of advanced glycosylation end products in diabetic nephropathy.
Shimoike T; Inoguchi T; Umeda F; Nawata H; Kawano K; Ochi H
Metabolism; 2000 Aug; 49(8):1030-5. PubMed ID: 10954022
[TBL] [Abstract][Full Text] [Related]
8. Oxidative damage to DNA and lipids: correlation with protein glycation in patients with type 1 diabetes.
Goodarzi MT; Navidi AA; Rezaei M; Babahmadi-Rezaei H
J Clin Lab Anal; 2010; 24(2):72-6. PubMed ID: 20333759
[TBL] [Abstract][Full Text] [Related]
9. The effect of hydrochloride pioglitazone on urinary 8-hydroxy -deoxyguanosine excretion in type 2 diabetics.
Wang Y; Ye S; Hu Y; Zhao L; Zheng M
J Diabetes Complications; 2013; 27(1):75-7. PubMed ID: 23021797
[TBL] [Abstract][Full Text] [Related]
10. Concentrations of urinary 8-hydroxy-2'-deoxyguanosine and 8-isoprostane in women exposed to woodsmoke in a cookstove intervention study in San Marcos, Peru.
Commodore AA; Zhang JJ; Chang Y; Hartinger SM; Lanata CF; Mäusezahl D; Gil AI; Hall DB; Aguilar-Villalobos M; Vena JE; Wang JS; Naeher LP
Environ Int; 2013 Oct; 60():112-22. PubMed ID: 24041735
[TBL] [Abstract][Full Text] [Related]
11. Elevated urinary levels of 8-oxo-2'-deoxyguanosine, (5'R)- and (5'S)-8,5'-cyclo-2'-deoxyadenosines, and 8-iso-prostaglandin F
Kant M; Akış M; Çalan M; Arkan T; Bayraktar F; Dizdaroglu M; İşlekel H
DNA Repair (Amst); 2016 Dec; 48():1-7. PubMed ID: 27769710
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of urinary 8-hydroxydeoxy-guanosine as a novel biomarker of macrovascular complications in type 2 diabetes.
Nishikawa T; Sasahara T; Kiritoshi S; Sonoda K; Senokuchi T; Matsuo T; Kukidome D; Wake N; Matsumura T; Miyamura N; Sakakida M; Kishikawa H; Araki E
Diabetes Care; 2003 May; 26(5):1507-12. PubMed ID: 12716813
[TBL] [Abstract][Full Text] [Related]
13. Assessing albuminuria in spot morning samples from diabetic patients.
Sampaio E; Delfino VD
Arq Bras Endocrinol Metabol; 2008 Dec; 52(9):1482-8. PubMed ID: 19197457
[TBL] [Abstract][Full Text] [Related]
14. Effect of glycemic control on microalbuminuria development among type 2 diabetes with high-normal albuminuria.
Chen WZ; Hung CC; Wen YW; Ning HC; Gau BR; Huang YY
Ren Fail; 2014 Mar; 36(2):171-5. PubMed ID: 24028605
[TBL] [Abstract][Full Text] [Related]
15. NLRP3 expression and urinary HSP72 in relation to biomarkers of inflammation and oxidative stress in diabetic nephropathy patients.
El-Horany HE; Abd-Ellatif RN; Watany M; Hafez YM; Okda HI
IUBMB Life; 2017 Aug; 69(8):623-630. PubMed ID: 28631886
[TBL] [Abstract][Full Text] [Related]
16. Urine Albumin-Creatinine Ratio Variability in People With Type 2 Diabetes: Clinical and Research Implications.
Rasaratnam N; Salim A; Blackberry I; Cooper ME; Magliano DJ; van Wijngaarden P; Varadarajan S; Sacre JW; Shaw JE
Am J Kidney Dis; 2024 Jul; 84(1):8-17.e1. PubMed ID: 38551531
[TBL] [Abstract][Full Text] [Related]
17. Association of the longitudinal trajectory of urinary albumin/creatinine ratio in diabetic patients with adverse cardiac event risk: a retrospective cohort study.
Li H; Ren Y; Duan Y; Li P; Bian Y
Front Endocrinol (Lausanne); 2024; 15():1355149. PubMed ID: 38745945
[TBL] [Abstract][Full Text] [Related]
18. Quantitative determination of urinary 8-hydroxy-2'-deoxyguanosine level in healthy Japanese volunteers.
Miwa M; Matsumaru H; Akimoto Y; Naito S; Ochi H
Biofactors; 2004; 22(1-4):249-53. PubMed ID: 15630292
[TBL] [Abstract][Full Text] [Related]
19. Expression levels of serum vasohibin-1 and other biomarkers in type 2 diabetes mellitus patients with different urinary albumin to creatinine ratios.
Ren H; Shao Y; Ma X; Yang M; Liu Y; Wang Q
J Diabetes Complications; 2019 Jul; 33(7):477-484. PubMed ID: 31097304
[TBL] [Abstract][Full Text] [Related]
20. The effect of L-thyroxine substitution on oxidative stress in early-stage diabetic nephropathy patients with subclinical hypothyroidism: a randomized double-blind and placebo-controlled study.
Chen Y; Wu G; Xu M
Int Urol Nephrol; 2018 Jan; 50(1):97-103. PubMed ID: 29196928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
